(Q39588207)

13 September 2017

title

ER stress is implicated in mitochondrial dysfunction-induced apoptosis of pancreatic beta cells (English)

1 reference

13 September 2017

June Woo Lee

1

1 reference

13 September 2017

Won Ho Kim

series ordinal

2

1 reference

13 September 2017

Jiyoung Yeo

series ordinal

3

1 reference

13 September 2017

Myeong Ho Jung

series ordinal

4

1 reference

13 September 2017

publication date

3 December 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

30

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

545-549

1 reference

https://scigraph.springernature.com/pub.10.1007/s10059-010-0161-5

13 September 2017

exact match

0 references

cites work

The role for endoplasmic reticulum stress in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Endoplasmic reticulum stress in beta-cells and development of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Ethidium bromide-induced inhibition of mitochondrial gene transcription suppresses glucose-stimulated insulin release in the mouse pancreatic beta-cell line betaHC9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Mitochondrial dysfunction: glucokinase downregulation lowers interaction of glucokinase with mitochondria, resulting in apoptosis of pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Depletion of mitochondrial DNA causes impaired glucose utilization and insulin resistance in L6 GLUT4myc myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Etiology of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Progressive accumulation of mitochondrial DNA mutations and decline in mitochondrial function lead to beta-cell failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

AMPK: an emerging drug target for diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10059-010-0161-5

10.1007/S10059-010-0161-5

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference